Brain cancer vaccine trial aims to boost Chemo's punch
Disease control
Not yet recruiting
This phase II trial tests a personalized dendritic cell vaccine (ZSNeo-DC1.1) combined with standard chemotherapy (temozolomide) in 78 adults with newly diagnosed glioblastoma. Participants receive the vaccine as shots during chemo after surgery and radiation. The goal is to see …
Phase: PHASE2 • Sponsor: ZSky Biotech Inc • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC